Toxics Law Reporter Index-Summary

DAMAGES

– Asbestos

– – Railroad worker's damages jury question (Miss.), 69
– – Short-term, decades old workplace exposure, award upheld (N.J. Super Ct.), 369
– – Wrongful death award, jury to assess Navy's fault (Cal. Ct. App.), 547

– Baycol and heart disease, economic injury class action bar (8th Cir.), 23; (U.S., rev grant), 1028
– Chinese drywall, sulfur gas

See SULFUR DIOXIDE

– CWA, Exxon Valdez oil spill, award allocation (U.S., rev sought), 4; (rev den), 181
– Fentanyl pain patch, Utah punitive immunity exception not barred (D. Utah), 969
– Hotel liability for bed bugs, Analysis & Perspective, 37
– HRT and breast cancer

– – Malice finding and award upheld (Nev.), 1233
– – Plaintiff opposes review of punitive award (U.S., brief filed), 555; (rev den), 618

– Indemnification, investigative costs constitute “damages” (E.D. Wash.), 835
– Insurance, BPA in baby products, economic-only claims (7th Cir.), 723
– Lead paint, learning disabilities in teen, manufacturer seeks to reverse award (Miss.), 702
– Manganese neurotoxicity, fault allocation error (5th Cir.), 879
– Medical monitoring claims increasingly allowed, Insight, 222
– Motrin, skin and liver injuries, Me. law governs damages claim (E.D. Pa.), 778
– Natural resource damages

See NATURAL RESOURCE DAMAGES

– Oil and gas

– – Gulf Coast Claims Facility, process and predictions, Insight, 985
– – Negligence, economic loss doctrine bars cleanup tort claim (9th Cir.), 698
– – Oil Pollution Act case may proceed on economic loss claim (W.D. La.), 350

– Pain pumps

– – Cal. law governs punitive damages suit (N.D. Ill.), 1280
– – Exemplary damages added for misconduct (D. Colo.), 1132
– – Punitive claims sufficient (S.D. Ohio), 1242

– Tobacco industry

– – Cancer death of smoker, award (Cal.), 51
– – False claims, harm to nonparties irrelevant to punitive award (Or.), 700

– World Trade Center rescue and recovery workers, fund proposed (S.D.N.Y.), 234; proposal rejected, 285; proposal revised, 588; approved, 638; deadline for settlement opt-in extended, 908; additional settlements reached, 1179; settlement to take effect, 1240

DATA COLLECTION

– MTBE, Cal. water district may use raw data from industry-funded study (S.D.N.Y.), 856
– Oil spills, Coast Guard may begin data collection, 923
– Water quality, data and monitoring, Insight, 927

DECLARATORY JUDGMENTS

– Oil spill, Gulf of Mexico, insurers seek ruling on coverage (S.D. Tex.), 544

DEFENSES

– Asbestos supplier may not assert sophisticated purchaser defense (Cal. Ct. App.), 1241
– Home seller with leaking fuel oil lacks state superfund defense (Wash. Ct. App.), 1318
– Learned intermediary doctrine

– – Metoclopramide, doctor's failure to read label dooms claim (5th Cir.), 1097
– – Product safety and liability, Insight, 503
– – Zyprexa and diabetes, summary ruling (2d Cir.), 724

– Preemption, regulatory compliance defense, Insight, 473
– Prospective purchaser defense and liability protection, Special Report, 1357
– Solvents from nuclear fuel plant, retrial granted (E.D.N.Y.), 517

DELAWARE

– Landfill, petroleum, cleanup, monitoring, 105
– Seroquel, diabetes link, suit untimely (Del. Super. Ct.), 1000
– USTs, gas station owner fined (D. Del.), 783

DENTAL CARE

– Fosamax and osteonecrosis

See FOSAMAX

DIABETES

– Avandia

See AVANDIA

– Prostate cancer, GnRH drug labels to include risks, 1132
– Seroquel

See SEROQUEL

– Veterinary insulin, pet's death, negligence (N.D. Ohio), 8
– Zyprexa

See ZYPREXA

DIACETYL

– Microwave popcorn purchasers, overbroad class (C.D. Cal.), 913
– Popcorn consumption and lung disease link not proved (E.D. Wash.), 726
– Popcorn workers' lung disease

– – Am. Pop Corn worker and wife, compensatory relief (N.D. Iowa), 367
– – BASF, jury award (Ill. Cir. Ct.), 939
– – Chemtura, bankruptcy settlement (S.D.N.Y.), 939

DIET DRUGS

– Fen-Phen class suit, lawyer disbarred for taking unearned fees (Ky.), 556
– Meridia, Abbott pulls drug from U.S. market, 1072
– Pondimin and pulmonary hypertension, suit time barred (U.S., rev den), 286
– Redux

– – Negligent design defect claim (Pa. Super. Ct.), 799
– – State negligence claims not barred (6th Cir.), 881; en banc hearing denied, 1098
– – Wyeth not liable for heart condition plaintiff did not develop (Pa. Super. Ct.), 775

DIETARY SUPPLEMENTS

See VITAMINS AND NUTRITIONAL SUPPLEMENTS

DIOXINS

– EPA releases draft reanalysis for comment, 527
– Herbicide, dioxin and furan waste, cancer claims remanded (S.D.W. Va.), 1027
– Soil pollution, EPA interim cleanup goals, 14; opposing views voiced, 355
– Waste-to-energy plant charged with excessive emissions (Conn. Super. Ct.), 866
– Water pollution, Mich., Dow Chem. cleanup, 55

DISCLOSURE

– Asbestos, incomplete disclosure justifies fraud suit against seller (W.D.N.C.), 1303
– Mold, homeowner's suit against real estate agent (Cal. Ct. App.), 911
– PCE, motion picture worker, skin rash, fraudulent concealment (Cal. Ct. App.), 93
– PFDA proposals, impact on product liability suits, Insight, 766
– Superfund, attorney-client privilege protects defense argument (Or. Ct. App.), 1184
– TSCA, lead paint, disclosure rules for residential leases (11th Cir.), 782
– Vapor intrusion, screening standard to be finalized by ATSM Intl., 382; date for standard issued, 441

DISCOVERY

– Asbestos, plaintiff's settlement data (E.D. Pa.), 53
– Gulf of Mexico oil spill, consolidated suits against BP, Transocean and others, discovery to begin (E.D. La.), 1239; status conference dates set, 1321; Transocean safety audit records ordered, 1355
– Pain pump, risk concealment discovery allowed (W.D. La.), 751
– Vapor intrusion, brownfields, due diligence may limit liability, attorney says, 524
– Zyprexa, expert's distribution of confidential documents (2d Cir.), 915

DISEASES

– AIDS, HIV-contaminated blood product, Taiwanese plaintiffs' claims time-barred (7th Cir.), 316
– Aneurysm, ephedra link, discovery time bar guidance sought (2d Cir.), 257
– Bacteria

See BACTERIA

– Blood pressure, Metroprolol, preemption (E.D. Mo.), 25
– Bone diseases

– – Benzene, bone marrow, testimony exclusion affirmed (5th Cir.), 997
– – Osteonecrosis

– – – Aredia

See AREDIA

– – – Fosamax

See FOSAMAX

– – – Zometa

See ZOMETA

– Botulism, Botox treatment, negligence award (Okla. Dist. Ct.), 486
– Brain damage

– – Cleaning solvent, railroad worker's FELA verdict (Ky.), 516
– – Ozone laundry system, suits not barred by workers' comp ruling (Utah), 520

– Cancer

See CANCER

– Cerebral palsy and Dursban link, causation not shown (8th Cir.), 1305
– Diabetes

See DIABETES

– Ear, nose, throat irritation, damages for Naphtha leak reduced (La,), 1122
– Endocrine disruptors, CWA criteria sought, 60
– Heart disease

See HEART DISEASE

– Hepatitis C outbreak from reused syringes for administering sedative, award (Nev. Dist. Ct.), 455
– Inflammatory bowel disease and Accutane

– – Evidence improperly barred, award vacated (N.J. Super. Ct.), 798
– – Personal injury suit, award (N.J. Super. Ct.), 160

– Kidney damage, gadolinium contrast dye

– – Plaintiff's experts, most allowed (N.D. Ohio), 457
– – Teen files claim (N.Y. Sup. Ct.), 372

– Liver disease

– – Cirrhosis, Tylenol, scientific evidence (N.Y. Sup. Ct.), 96
– – Duract, unjust enrichment from third-party payers, class decertified (Ala.), 135
– – Motrin, Me. law governs punitive damages claim (E.D. Pa.), 778
– – Steroid in dietary supplement P-Drol, permanent damage alleged (Tex. Dist. Ct.), 137

– Lung disease

See LUNG DISEASE

– Manganese exposure

– – Neurotoxicity, fault allocation error (5th Cir.), 879
– – Parkinson's, speculative expert testimony (6th Cir.), 941

– Meningitis and Trovan clinical trials, Nigerian families may sue Pfizer (U.S., rev den), 663
– Neurological ailments from cold medicine, causation testimony unreliable (Iowa), 159
– Radiation exposure from imaging devices, Insight, 896
– Skin reactions

– – Cement burns, home owner's warning claims (E.D.N.Y.), 162
– – Diaper “Dry Max” gel, burns alleged (S.D. Ohio), 487
– – Hexavalent chromium, evidence (W.D. La.), 76
– – Lamisil, Tex. labeling claim not barred (D.N.J.), 944
– – Motrin

– – – Contributory negligence ruling affirmed (7th Cir.), 823
– – – Labeling, preemption, adequacy presumption, fraud (N.D. Tex.), 97
– – – Punitive damages claim governed by Me. law (E.D. Pa.), 778

– – Paint fumes, chemical sensitivity testimony rejected (Kan.), 1123
– – PCE, motion picture worker, fraudulent concealment (Cal. Ct. App.), 93
– – Phenytoin sodium, negligence claims may proceed (S.D. Miss.), 1031
– – Refinery dust exposure at battle reenactment, class certified (E.D. La.), 617

– Stroke, Viagra, causation evidence lacking (E.D. La.), 456
– Tardive dyskinesia

See METOCLOPRAMIDE

– Tendon injuries

– – Ciprofloxacin link, claim against Bayer may proceed (W.D. La.), 400
– – Levaquin

– – – Learned intermediary doctrine does not bar suit (D. Minn.), 777
– – – Rupture, petitions to FDA admissible (D. Minn.), 1212; jury finds for plaintiff, 1308

DOJ

See JUSTICE DEPARTMENT (DOJ)

DRINKING WATER

– Cal., L.A. county, non-settling party may intervene in consent decree (9th Cir,), 561
– CWA, Bull Run power plant, TVA permit challenged, 1163
– Herbicide atrazine, class action suit filed against agribusiness firm Syngenta (S.D. Ill.), 208
– Mercury, N.Y. agency, probation ends (S.D.N.Y.), 12
– Metals, natural gas drilling contaminated water wells (N.D. Tex.), 1332
– Military bases, toxic exposures at N.C. and Japan, health care bill approved, 99; Navy to pay for Camp Lejeune mortality study, 164; personal injury suit, limitations period, sovereign immunity (E.D.N.C.), 182; repose law exception allows suit, 1208
– MTBE

– – Cal. water district may use raw data from industry-funded study (S.D.N.Y.), 856
– – N.Y. and Fla., settlement (S.D.N.Y.), 796

– Oil and gas, radioactive materials, bankruptcy (3d Cir.), 8
– Outlook 2010, 127
– PCBs, Hudson River, EPA to fund other water source during dredging, 405
– Perchlorate, noncompliance with Natl. Contingency Plan (9th Cir.), 801; (U.S., rev den), 1247
– PFOA

– – EPA consent order and RCRA citizens' suit (S.D. Ohio), 918
– – N.J. nuisance law, class certification (3d Cir.), 4

– RCRA, pharmaceutical waste in N.Y. drinking water, 59
– Top 2010 issues, 127

DRUGS

See PHARMACEUTICALS

DUE PROCESS

– Lead paint, risk-utility rule violates due process rights (E.D. Wis.), 666; remaining defendants win reprieve, 1210
– Superfund, unilateral §106 order issued without hearing challenged (D.C. Cir.), 491; challenge denied, 673
– Tobacco, La. smoker class, Scalia halts payment (U.S., judgment stayed), 996; (rev sought), 1310

DUST

– Animal feed makers, chromium and manganese, EPA emissions cuts, 15
– CWA, coal dust in Seward waters, railroad and mining (D. Alaska), 30
– Pollution exclusion clause bars dust damages against construction firm (3d Cir.), 597
– Refinery dust exposure at battle reenactment, class certified (E.D. La.), 617
– Silica, lung disease, workers' compensation, causation testimony (Tenn.), 22
– World Trade Center rescue and recovery workers, fund proposed (S.D.N.Y.), 234; proposal rejected, 285; proposal revised, 588; approved, 638; deadline for settlement opt-in extended, 908; additional settlements reached, 1179; settlement to take effect, 1240